Additionally, iron deficiency was the major cause of anemia, and indoxyl sulfate also affected iron metabolism in CKD by participating in hepcidin regulation through AhR-dependent pathways, suggesting that indoxyl sulfate-induced AhR may be exploited as a therapeutic target for treating renal anemia [71]. This evidence concerns the gene AHR and anemia.